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INTRODUCTION
A number of clinical studies have shown that inflammation plays an important role in the pathogenesis of atherosclerosis [1, 2] . Despite improvements in surgical and anesthetic management of coronary artery bypass grafting (CABG) and myocardial protection, a notable reduction in the incidence of postoperative cardiac arrhythmias could not be detected. Although patients tolerate postoperative atrial fibrillation (AF) well, it can be associated with haemodynamic instability, prolonged hospitalization, thromboembolic complications, increased health costs, morbidity and mortality [3] .
Inflammation plays a major role at all stages of atherosclerosis, including initiation and progression and in the thrombotic complications [4] . AF is also closely linked to inflammation [5] . Dernellis et al. [6] observed that increased levels of C-reactive protein (CRP) predict the development of AF, which is closely linked to inflammation.
Recently, the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio, which are obtained from complete blood count parameters, are potential markers of inflammation that have been shown to have prognostic value in various cardiovascular diseases. These 2 parameters have also been shown to have negative prognostic value in CABG operations [7, 8] . Recently, monocyte to high-density lipoprotein cholesterol ratio (M/HDL-C) was defined as a potential marker to predict cardiovascular events [9] .
Our goal was to investigate the association of the M/HDL-C ratio with postoperative AF and mortality in patients having an isolated CABG operation.
MATERIAL AND METHODS
A total of 1012 patients who had cardiac surgery in the same clinic by the same surgical team between 2010 and 2014 were enrolled retrospectively. Six hundred and sixty-two patients (65.4%) with preoperative normal sinus rhythm who were operated with isolated CABG with cardiopulmonary bypass (CPB) were accepted in this study. Patients were excluded who had previously known peripheral arterial disease; preoperative AF; valvular heart disease; left ventricular systolic function disorder (left ventricular ejection fraction < _ 30%); congenital cardiac disease; cerebrovascular disease; renal impairment (serum creatinine >2 mg/dl); advanced age (>75 years); chronic obstructive pulmonary disease; endocrinological disorders (hyperthyroidism, hypothyroidism); systemic inflammatory diseases; malignancy; hematological diseases; and low haemoglubin (Hgb) levels (< _10 g/dl). Also excluded were patients who were severely obese (body mass index >30 kg/m 2 ); patients with a left atrium diameter >4.5 cm on echocardiographic scans; patients with acute infections, atrial and ventricular arrhythmia, emergency operations; patients who were reoperated due to haemodynamic instability or bleeding; patients who required an intra-aortic balloon pump; patients who were operated off pump or who had redo CABG; and patients who were taking anti-inflammatory drugs [10] .
Group 1 (n = 153) included patients who developed AF and group 2 (n = 509) included those who remained in normal sinus rhythm during the first 7 postoperative days.
The demographic and clinical data of the patients were obtained from their electronic medical records and other hospital records. Age, gender, smoking history, diabetes, hypertension, hyperlipidemia, left ventricular ejection fraction, left atrium diameter, preoperative and postoperative laboratory parameters (haemoglobin, haematocrit leukocyte count, thrombocyte count, monocyte count, CRP, total cholesterol, low density lipoprotein [LDL] cholesterol, HDL cholesterol, fasting blood glucose, creatinine) operation information, the number of grafts used, duration of CPB and aortic cross-clamp, amount of blood products used and length of stay in the intensive care unit and hospital were recorded. The preoperative basal heart rates of the patients were obtained by analysing 12-lead electrocardiographic (ECG) records. As described by S¸as¸kın H. et al. [10] , hypertension was defined as blood pressure > _140/ 90 mmHg or use of antihypertensive drugs; the person was considered a smoker if he or she had not quit smoking for the last year; and diabetes was defined as fasting blood glucose level > _126 mg/dl or the use of antidiabetic drugs. Hyperlipidemia was defined as total cholesterol >220 mg/dl and LDL-cholesterol >130 mg/dl or the use of antihyperlipidaemic drugs.
Venous blood samples of approximately 5-7 ml were placed in a sterile tube with EDTA preoperatively. Hematological parameters were calculated using an automated blood count device (Abbott CELL-DYN 3700; Abbott Laboratory, Abbott Park, IL, USA) following a waiting time of 1 h. Serum levels of total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides were determined in all specimens using an automatic multichannel biochemical analyzer (Hitachi-7450, Hitachi, Tokyo, Japan) following routine laboratory procedures in our hospital. The M/ HDL-C ratio was calculated by dividing the number of monocytes by the HDL cholesterol level.
The diagnosis of postoperative AF was made using a standard 12-derivation ECG. Death during the time in the hospital following the operation or during the first 30 postoperative days was defined as postoperative early-term mortality. The patients were followed with continuous ECG monitoring both in the intensive care unit and in the wards for 7 days. AF was diagnosed by the absence of p waves and irregular ventricular rhythm on the ECG scan.
All of the patients were transferred to the intensive care unit intubated. They were extubated after onset of spontaneous breathing and normal orientation and cooperation if the haemodynamic and respiratory functions were appropriate. The patients received continuous ECG monitoring in the intensive care unit and during the first 72 h in the inpatient room. If there was no contraindication, all patients were given 50 mg/day of oral metoprolol after the first postoperative day. The patients were prescribed atorvastatin 20 mg/daily and acetylsalicylic acid 150 mg starting on the first postoperative day; and antihypertensive agents were given based on the follow-up values. The patients were followed by a rhythm ECG taken once a day; pulse and arterial blood pressure measurements were taken at maximum intervals of 4 h in the inpatient room. AF was defined as any documented AF lasting more than 5 minutes. If it was necessary to control heart rate in the treatment of AF, intravenous (IV) metoprolol (5-10 mg) was administered. To all patients who needed it, a bolus intravenous dose of 300 mg amiodarone was given in 1 hour's time with a maintenance dose of intravenous 900 mg amiodarone continued in the next 24 h followed by 200 mg amiodarone orally thrice daily. During the whole AF period, low-molecular-weight heparin was given based on the patient's weight. Patients for whom normal cardiac sinus rhythm could not be established were discharged with oral warfarin.
This study complied with the Declaration of Helsinki and was carried out following approval of the Ethics Committee for Clinical Trials of the Medical Faculty of Kocaeli University.
OPERATIVE TECHNIQUE
Median sternotomy was performed under routine anesthesia during the operation. Bypass grafts (saphenous vein and internal mammary artery) were prepared. Systemic heparinization was ensured by administrating 300 IU/kg heparin such that activated clotting time would be greater than 450 seconds. CPB was initiated by 2-stage venous and ascending aorta cannulation. In all patients, a non-pulsatile roller pump and membrane oxygenator were used for CPB. Surgical procedures were carried out under conditions of moderate systemic hypothermia (28-30 C). CPB was applied such that the flow rate would be 2.2 to 2.5 l/min/m 2 ; the mean perfusion pressure would be between 50 and 80 mmHg; and haematocrit values would be between 20% and 25%. Myocardium protection was done via antegrade hypothermic and hyperpotassemic blood cardioplegia. In all cases, the left internal mammary artery was used as a graft in the revascularization of the left anterior ascendant artery, and the saphenous vein was used as a graft in the revascularization of other coronary arteries. All proximal anastomoses were done in the heart working under partial clamp in all of the operated patients.
Statistical analysis
Statistical analyses were performed using the SPSS software version 12.0 (SPSS Inc, Chicago, IL, USA). Among the data measured, those showing normal distribution were expressed as mean ± standard deviation; those not showing normal distribution were expressed as median (minimum-maximum). The data obtained by counting were given as percentages. Among the data measured, the normality of distribution was evaluated by histogram or the Kolmogorov-Smirnov test, and the homogeneity of distribution was evaluated by Levene's test for equality of variances. For the data measured, the difference between the groups was evaluated by the Student t-test for normal and homogeneous distribution and by the Mann-Whitney U test for distribution that was not normal and homogeneous. For the data obtained by counting, the differences between the groups were evaluated by the parametric or non-parametric Pearson Chi-square test or the Fisher Exact test depending on whether the distribution was parametric or not. The effects of those risk factors thought to have an influence on early mortality and AF were studied using univariate logistic regression analysis. The multiple effects of the risk factors that are thought to be influential in predicting mortality rates and AF as a result of the univariate statistical analysis were studied using retrospective selective multivariate logistic regression analysis. The odds ratio, the 95% confidence interval and the significant level for each of the risk factors were found. The sensitivity and the specificity of M/HDL-C ratio in predicting mortality and AF via the receiver operating curve (ROC) were computed, and results were considered statistically significant if P < 0.05.
RESULTS
Patient demographics and clinical data are summarized in Table 1 . There were no differences between the 2 groups in terms of demographic or clinical data.
The preoperative blood analysis and haematological parameters of the patients are summarized in Table 2 . Monocyte counts (P = 0.0001), M/HDL-C ratio (P = 0.0001) and CRP levels (P = 0.0001) were significantly different between the groups.
The intraoperative and postoperative data of the patients are shown in Table 2 . There were no statistically significant differences between the 2 groups in terms of intraoperative and postoperative data. The average number of distal anastomoses was 3.30 ± 0.89 (median: 3, range: 1-5) in group 1, and 3.22 ± 0.91 (median: 3, range: 1-7) in group 2, which was not statistically significant (P = 0.24).
The average haemoglubin (g/dl) values on the first postoperative day were 9.1 ± 1.2 (median: 8.9, range: 7.2-13.1) in group 1 and 9.2 ± 1.1 (median: 9.0, range: 7.4-12.7) in group 2; the difference between the groups was not statistically significant (P = 0.21). The first postoperative day average CRP (mg/dl) levels were 26.0 ± 5.2 (median: 26.1, range: 15.8-39.4) in group 1, and 26.4 ± 5.3 (median: 25.1, range: 12.2-40.1) in group 2; the difference between the groups was not statistically significant (P = 0.37). The leukocyte counts for the first postoperative day in groups 1 and 2 were 11.1 ± 2.9 (median: 10.7, range: 4.6-21.1) x 10 3 /ml and 11.3 ± 3.0 (median: 10.9, range: 5.1-26.4) x 10 3 /ml, respectively, for which the difference was not statistically significant (P = 0.55).
AF occurred in the first 8 postoperative hours in 34 patients (22.2%); between the 9th and 24th h in 41 patients (26.8%); between the 25th and 72nd h in 59 patients (38.6%) and after 72 h in 19 patients (12.4%).
This study included a total of 662 patients who were evaluated retrospectively: AF occurred in 153 patients (23.1%) in-hospital; 141 patients (92.2%) who developed AF returned to normal sinus rhythm with amiodarone therapy; 5 patients (3.2%) were discharged following conversion to sinus rhythm with electrical cardioversion. Seven patients (4.6%) for whom appropriate rate control could not be established, were discharged with AF rhythm and oral anticoagulant (warfarin sodium) therapy. Eight (5.2%) patients died in the first postoperative month in group 1 and 5 patients (1.0%) in group 2; the difference between the groups was highly statistically significant (P = 0.003).
The average length of stay in the hospital was 6.6 ± 1.0 (median: 7, range: 5-9) days in group 1 and 5.3 ± 1.1 (median: 5, range: 5-18) days in group 2. When the lengths of stays in the hospital of the 2 groups were compared, the difference between the 2 groups was highly significant (P = 0.0001).
The results of univariate and multivariate regression analysis of patients who developed AF in the postoperative period are shown in Tables 3 and 4 . With univariate analysis, preoperative monocyte count (P = 0.0001), preoperative M/HDL-C ratio (P = 0.0001) and preoperative CRP (P = 0.0001) were found to be associated with occurrence of postoperative AF. In multivariate regression analysis of these variables, preoperative CRP (OR: 15.17, 95% CI: 7.81-29.48, P = 0.0001) and preoperative M/HDL-C ratio (OR: 11.51, 95% CI: 1.25-106.67, P = 0.03) were detected as independent risk factors for the occurrence of AF in the postoperative period.
The results of univariate and multivariate regression analyses of patients who died in the early postoperative period are shown in Tables 5 and 6 . With univariate analysis, hyperlipidemia (P = 0.04), preoperative monocyte count (P = 0.0001), preoperative M/HDL-C ratio (P = 0.0001), intubation time (P = 0.02) and use of inotropic support (P = 0.0001) were found to be associated with mortality in the early postoperative period. In multivariate regression analyses of these variables, preoperative monocyte count (OR: 1.19, 95% CI: 1.05-1.34, P = 0.001), preoperative M/HDL-C ratio (OR: 1.87, 95% CI: 1.33-2.63, P = 0.0001) and use of inotropic support (OR: 23.30, 95% CI: 4.41-123.21, P = 0.0001) were detected as independent risk factors for mortality in the early postoperative period. The ROC curves for the M/HDL-C ratio were associated with AF following CABG (Fig. 1) . The area under curve for the preoperative M/HDL-C ratio was 0.835 (95% CI: 0.799-0.870; P = 0.0001). Using a cut-off value of 0.0185, the preoperative M/HDL-C ratio predicted postoperative AF with a sensitivity of 86.9% and a specificity of 72.5%.
The ROC curves for the M/HDL-C ratio were related to mortality following CABG (Fig. 2) . The area under curve for the preoperative M/HDL-C ratio was 0.872 (95% CI: 0.805-0.940; P = 0.0001). Using a cut-off value of 0.205, the preoperative M/HDL-C ratio predicted mortality with a sensitivity of 84.6% and a specificity of 81.0%.
DISCUSSION
In this study, an elevated preoperative M/HDL-C ratio was associated with in-hospital and early postoperative mortality and AF after an isolated CABG operation. To the best of our knowledge, this is the first study to evaluate the association of the M/HDL-C ratio with in-hospital and early postoperative mortality and AF after a CABG operation.
Morbidity and complications associated with CABG operation diminish the quality of life of the patient and increase health costs [11] . We investigated several risk models to estimate mortality and morbidity associated with CABG and several blood markers [12] . Inflammation plays an important role in the formation of atherosclerosis and may be linked with plaque rupture in the presence of risk factors [13] . White blood count, elevated peripheral blood platelet count, low lymphocyte count, neutrophil to lymphocyte ratio, CRP and platelet to lymphocyte ratio are inflammatory markers that have recently been shown to have prognostic value in the atherosclerotic process [8, 14] .
Monocytes are one of the essential components of the human immune system. They are involved in various phases of the atherosclerotic process and are closely linked with the inflammatory process in the vulnerable plaques [15] . Monocyte activation is a key step in the atherosclerotic process. Monocytes, which are the source of macrophages and foam cells, are closely associated with plaque development and play a key role in all stages of the disease [16, 17] . Monocyte counts have recently been postulated as a predictor of coronary events [14] . It has been shown that HDL cholesterol has anti-inflammatory, antioxidant and antithrombotic effects that are important for protecting against atherosclerosis and other inflammatory diseases [18, 19] . HDL also inhibits endothelial expression of adhesion molecules and prevents monocyte infiltration to the artery wall [20] . It has been observed that plasma levels of HDL were inversely associated with cardiovascular morbidity and mortality [21] .
It has been shown that lower levels of HDL are associated with a worse prognosis in critically ill patients and those with infective endocarditis [22] . In a recent study, lower levels of LDL cholesterol and HDL cholesterol were predictors of short-term mortality after myocardial infarction [23] . Kim et al. [24] showed that elevated levels of CRP and decreased levels of HDL cholesterol predicted mortality in patients with cancer and cardiovascular disease. They suggested that this association may be linked to inflammation.
The monocyte to HDL-C ratio was recently defined as a potential marker to predict clinical outcome in some trials. Kanbay et al. [25] observed that the M/HDL-C ratio was associated with poor outcome in patients with chronic kidney disease. Canpolat et al. [26] observed that the M/HDL-C ratio was associated with AF recurrences after cryoballoon-based catheter ablation in AF ablation. We have also observed that the M/HDL-C ratio was associated with postoperative AF. To the best of our knowledge, this is the first study showing this association.
Karatas¸et al. [14] observed that the M/HDL-C ratio was associated with prognosis in patients with myocardial infarction. Both experimental and clinical investigators have observed that postoperative AF is multifactorial. In addition to the surgical factors, inflammation and beta-adrenergic activation have been shown to play a prominent role in its pathogenesis. In our study, an elevated preoperative monocyte count and M/HDL-C ratio were predictors of early postoperative mortality in patients who had isolated CABG operations. In recent studies, the M/HDL-C ratio has been linked to coronary artery disease, and AF may be a promising marker in the field of cardiovascular disease.
Limitations
A few limitations of our study deserve mention. It is a singlecentre retrospective study with a relatively small sample size. Another limitation is the fact that our patients exhibited a relatively wide range of Confidence interval (Ci). Although we have found some parameters associated with mortality and AF, we could not draw a causal relationship. Due to the retrospective nature of the study, the inflammatory parameters associated with mortality need to be analysed in a large prospective study.
CONCLUSIONS
In our study, we observed that an elevated M/HDL-C ratio was an independent predictor of early mortality and postoperative AF. The M/HDL-C ratio, which can easily be obtained from a simple complete blood count, may predict adverse events after CABG. Although we could not establish a causal relationship, the results of this study may have some clinical implications if the study is approved for large-scale prospective trials.
